Diffusion Pharmaceuticals Inc. entered into an amendment to a pre-funded warrant with The Joshua S. Boger 2021 Trust DTD 12/09/2021, eliminating a limitation on exercise that would result in the Holder's ownership exceeding 9.99% of the company's outstanding common stock. The Trust exercised the warrant in full and received 495,959 shares of common stock.